ArticleArchives of orthopaedic and trauma surgery2025
Development of a simple clinical score to estimate in-hospital adverse event risk after elective hip arthroplasty: a retrospective cohort study in a high-risk population.
Article in Archives of orthopaedic and trauma surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionPatients undergoing total hip arthroplasty (THA) in tertiary centres often present with complex comorbidities that increase the risk of perioperative adverse events (AE). While fast-track and outpatient protocols are expanding, reliable risk stratification tools tailored to high-risk European populations remain limited. This study aimed to (1) compare comorbidity burden in a high-risk population to national data, (2) determine incidence and risk factors for in-hospital AE and (3) develop a simple, pragmatic score to identify patients at elevated AE risk. MATERIALS AND
methodsWe retrospectively analyzed 4,101 elective primary THA cases from a German tertiary care centre (2010-2019). Comorbidity burden was quantified using the Elixhauser Comorbidities (EC) and benchmarked against national registry data (EPRD). Independent predictors of in-hospital AE were identified using multivariate logistic regression. These variables were then used to develop a pragmatic preoperative clinical risk score via LASSO regression, internally validated with 10-fold cross-validation and bootstrapping.
resultsCompared to the national registry, our cohort showed significantly higher rates of major comorbidities, including cardiac valvular disease, diabetes, and fluid/electrolyte disorders. The overall in-hospital AE rate was 2.6%. Six comorbidities-including pulmonary circulation disorders (OR 10.7, 95% CI: 3.6-31.8)-were independently associated with AE. The derived LASSO model demonstrated strong discrimination (AUC 0.80; 95% CI: 0.75-0.84) and calibration (Brier score 0.07). A cutoff score ≥ 2 identified patients with an AE rate of > 7%, while scores < 2 corresponded to an NPV of 0.99, supporting its utility in identifying low-risk patients for fast-track pathways.
conclusionsPatients treated in tertiary centres exhibit elevated comorbidity burden but maintain acceptable perioperative AE rate. A simple, validated clinical score can flag patients at substantially increased risk of in-hospital AE who may benefit from closer in-hospital surveillance and effectively identify low-risk candidates for fast-track THA pathways. Further external validation is warranted.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.